The role of complement in trauma and fracture healing

Seminars in Immunology

Volumn 25, Issue 1, 2013, Pages 73-78

  Huber Lang, Markus ^a   Kovtun, Anna ^a   Ignatius, Anita ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Bone; Complement; Fracture; Trauma

Indexed keywords

COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; BONE; BONE CELL; BONE METABOLISM; BONE TURNOVER; CELL KILLING; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; FRACTURE; FRACTURE HEALING; HUMAN; INJURY; INNATE IMMUNITY; NONHUMAN; REVIEW; SEPSIS; TISSUE REGENERATION;

BONE; COMPLEMENT; FRACTURE; TRAUMA;

ANIMALS; APOPTOSIS; BLOOD COAGULATION; COMPLEMENT SYSTEM PROTEINS; FRACTURE HEALING; HUMANS; IMMUNITY, INNATE; OSTEOGENESIS; RECEPTORS, PATTERN RECOGNITION; REGENERATION; WOUNDS AND INJURIES;

EID: 84879879893     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.05.006     Document Type: Review

References (66)

1. Lim S.S., Vos T., Flaxman A.D., Danaei G., Shibuya K., Adair-Rohani H., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2224-2260.
2. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223.
3. Probst C., Pape H.C., Hildebrand F., Regel G., Mahlke L., Giannoudis P., et al. 30 years of polytrauma care: an analysis of the change in strategies and results of 4849 cases treated at a single institution. Injury 2009, 40(1):77-83.
4. Denk S., Perl M., Huber-Lang M. Damage- and pathogen-associated molecular patterns and alarmins: keys to sepsis?. European Surgical Research 2012, 48(4):171-179.
5. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296(5566):301-305.
6. Keel M., Trentz O. Pathophysiology of polytrauma. Injury 2005, 36(6):691-709.
7. Gebhard F., Bruckner U.B., Strecker W., Kinzl L. Untersuchungen zur systemischen posttraumatischen Inflammation in der Frühphase nach Trauma 2000, Springer.
8. Xiao W., Mindrinos M.N., Seok J., Cuschieri J., Cuenca A.G., Gao H., et al. A genomic storm in critically injured humans. Journal of Experimental Medicine 2011, 208(13):2581-2590.
9. Huber-Lang M., Sarma J.V., Lu K.T., McGuire S.R., Padgaonkar V.A., Guo R.F., et al. Role of C5a in multiorgan failure during sepsis. Journal of Immunology 2001, 166(2):1193-1199.
10. Rittirsch D., Redl H., Huber-Lang M. Role of complement in multiorgan failure. Clinical and Developmental Immunology 2012, Arcticle ID 962927. 10.1155/2012/962927.
11. Schoengraf P., Lambris J.D., Recknagel S., Kreja L., Liedert A., Brenner R.E., et al. Does complement play a role in bone development and regeneration?. Immunobiology 2013, 218(1):1-9.
12. Kono H., Rock K.L. How dying cells alert the immune system to danger. Nature Reviews Immunology 2008, 8(4):279-289.
13. Brohi K., Cohen M.J., Ganter M.T., Matthay M.A., Mackersie R.C., Pittet J.F. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Annals of Surgery 2007, 245(5):812-818.
14. Amara U., Flierl M.A., Rittirsch D., Klos A., Chen H., Acker B., et al. Molecular intercommunication between the complement and coagulation systems. Journal of Immunology 2010, 185(9):5628-5636.
15. Köhl J. The role of complement in danger sensing and transmission. Immunologic Research 2006, 34(2):157-176.
16. Burk A.M., Martin M., Flierl M.A., Rittirsch D., Helm M., Lampl L., et al. Early complementopathy after multiple injuries in humans. Shock 2012, 37(4):348-354.
17. Fosse E., Mollnes T.E., Aasen A.O., Trumpy J.H., Stokke T. Complement activation following multiple injuries. Acta Chirurgica Scandinavica 1987, 153(5-6):325-330.
18. Fosse E., Pillgram-Larsen J., Svennevig J.L., Nordby C., Skulberg A., Mollnes T.E., et al. Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury 1998, 29(7):509-514.
19. Hecke F., Schmidt U., Kola A., Bautsch W., Klos A., Köhl J. Circulating complement proteins in multiple trauma patients - correlation with injury severity, development of sepsis, and outcome. Critical Care Medicine 1997, 25(12):2015-2024.
20. Ganter M.T., Brohi K., Cohen M.J., Shaffer L.A., Walsh M.C., Stahl G.L., et al. Role of the alternative pathway in the early complement activation following major trauma. Shock 2007, 28(1):29-34.
21. Ward P.A. The dark side of C5a in sepsis. Nature Reviews Immunology 2004, 4(February (2)):133-142.
22. Flierl M.A., Perl M., Rittirsch D., Bartl C., Schreiber H., Fleig V., et al. The role of C5a in the innate immune response after experimental blunt chest trauma. Shock 2008, 29(1):25-31.
23. Flierl M.A., Smith W.R., Morgan S.J., Stahel P.F. Molecular mechanisms and management of traumatic brain injury - missing the link?. World Journal of Emergency Surgery 2009, 4:10.
24. Bhandari M., Tornetta P., Sprague S., Najibi S., Petrisor B., Griffith L., et al. Predictors of reoperation following operative management of fractures of the tibial shaft. Journal of Orthopaedic Trauma 2003, 17(May (5)):353-361.
25. Recknagel S., Bindl R., Kurz J., Wehner T., Schoengraf P., Ehrnthaller C., et al. C5aR-antagonist significantly reduces the deleterious effect of a blunt chest trauma on fracture healing. Journal of Orthopaedic Research 2012, 4:581-586.
26. Gerard C. Complement C5a in the sepsis syndrome - too much of a good thing?. New England Journal of Medicine 2003, 348(2):167-169.
27. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nature Medicine 2006, 12(6):682-687.
28. Hajishengallis G., Lambris J.D. Crosstalk pathways between Toll-like receptors and the complement system. Trends in Immunology 2010, 31(4):154-163.
29. Hüttenrauch F., Pollok-Kopp B., Oppermann M. G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers. Journal of Biological Chemistry 2005, 280(45):37503-37515.
30. Markiewski M.M., Nilsson B., Ekdahl K.N., Mollnes T.E., Lambris J.D. Complement and coagulation: strangers or partners in crime?. Trends in Immunology 2007, 28(4):184-192.
31. Kanse S.M., Gallenmueller A., Zeerleder S., Stephan F., Rannou O., Denk S., et al. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a. Journal of Immunology 2012, 188(6):2858-2865.
32. Oikonomopoulou K., Ricklin D., Ward P.A., Lambris J.D. Interactions between coagulation and complement - their role in inflammation. Seminars in Immunopathology 2012, 34(1):151-165.
33. Kambas K., Markiewski M.M., Pneumatikos I.A., Rafail S.S., Theodorou V., Konstantonis D., et al. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. Journal of Immunology 2008, 180(11):7368-7375.
34. Rittirsch D., Flierl M.A., Nadeau B.A., Day D.E., Huber-Lang M.S., Grailer J.J., et al. Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system. American Journal of Physiology: Lung Cellular and Molecular Physiology 2013, Epub ahead of print. PMID:23564505.
35. Perl M., Denk S., Kalbitz M., Huber-Lang M., Granzyme B. a new crossroad of complement and apoptosis. Advances in Experimental Medicine and Biology 2012, 946:135-146.
36. Huber-Lang M., Denk S., Fulda S., Erler E., Kalbitz M., Weckbach S., et al. Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro. Molecular Immunology 2012, 50(1-2):60-65.
37. Guo R.F., Sun L., Gao H., Shi K.X., Rittirsch D., Sarma V.J., et al. In vivo regulation of neutrophil apoptosis by C5a during sepsis. Journal of Leukocyte Biology 2006, 80:1575-1583.
38. Yousefi S., Mihalache C., Kozlowski E., Schmid I., Simon H.U. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death and Differentiation 2009, 16(11):1438-1444.
39. Hawlisch H., Belkaid Y., Baelder R., Hildeman D., Gerard C., Köhl J. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 2005, 22(4):415-426.
40. Rittirsch D., Flierl M.A., Ward P.A. Harmful molecular mechanisms in sepsis. Nature Reviews Immunology 2008, 8:776-787.
41. Zhang X., Kimura Y., Fang C., Zhou L., Sfyroera G., Lambris J.D., et al. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 2007, 110(1):228-236.
42. Amara U., Kalbitz M., Perl M., Flierl M.A., Rittirsch D., Weiss M., et al. Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans. Shock 2010, 33(6):568-575.
43. MacLeod J.B., Lynn M., McKenney M.G., Cohn S.M., Murtha M. Early coagulopathy predicts mortality in trauma. Journal of Trauma 2003, 55(1):39-44.
44. Stahel P.F., Morganti-Kossmann M.C., Perez D., Redaelli C., Gloor B., Trentz O., et al. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury. Journal of Neurotrauma 2001, 18(8):773-781.
45. Heeres M., Visser T., van Wessem K.J., Koenderman A.H., Strengers P.F., Koenderman L., et al. The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - the CAESAR study: study protocol for a randomized controlled trial. Trials 2011, 12:223.
46. Dominiak B., Oxberry W., Chen P. Study on a nonhealing fracture from a patient with systemic lupus erythematosus and its pathogenetic mechanisms. Ultrastructural Pathology 2005, 29(March-April (2)):107-120.
47. Sontheimer R.D., Racila E., Racila D.M. C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. Journal of Investigative Dermatology 2005, 125(July (1)):14-23.
48. Konttinen Y.T., Ceponis A., Meri S., Vuorikoski A., Kortekangas P., Sorsa T., et al. Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane. Annals of the Rheumatic Diseases 1996, 55(12):888-894.
49. Neumann E., Barnum S.R., Tarner I.H., Echols J., Fleck M., Judex M., et al. Local production of complement proteins in rheumatoid arthritis synovium. Arthritis and Rheumatism 2002, 46(4):934-945.
50. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nature Medicine 2011, 17(12):1674-1679.
51. Hajishengallis G., Liang S., Payne M.A., Hashim A., Jotwani R., Eskan M.A., et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host & Microbe 2011, 10(November (5)):497-506.
52. Liang S., Krauss J.L., Domon H., McIntosh M.L., Hosur K.B., Qu H., et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. Journal of immunology 2011, 186(January (2)):869-877.
53. Recknagel S., Bindl R., Brochhausen C., Göckelmann M., Wehner T., Schoengraf P., et al. Systemic inflammation induced by a thoracic trauma alters the cellular composition of the early fracture callus. Journal of Trauma and Acute Care Surgery 2013, 74(February (2)):531-537.
54. Recknagel S., Bindl R., Kurz J., Wehner T., Ehrnthaller C., Knöferl M.W., et al. Experimental blunt chest trauma impairs fracture healing in rats. Journal of Orthopaedic Research 2011, 29(5):734-739.
55. Ignatius A., Ehrnthaller C., Brenner R.E., Kreja L., Schoengraf P., Lisson P., et al. The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro. Journal of Trauma 2011, 71(4):952-960.
56. Nakagawa K., Sakiyama H., Fukazawa T., Matsumoto M., Takigawa M., Toyoguchi T., et al. Coordinated change between complement C1s production and chondrocyte differentiation in vitro. Cell and Tissue Research 1997, 289(August (2)):299-305.
57. Sakiyama H., Inaba N., Toyoguchi T., Okada Y., Matsumoto M., Moriya H., et al. Immunolocalization of complement C1s and matrix metalloproteinase 9 (92kDa gelatinase/type IV collagenase) in the primary ossification center of the human femur. Cell and Tissue Research 1994, 277(August (2)):239-245.
58. Andrades J.A., Nimni M.E., Becerra J., Eisenstein R., Davis M., Sorgente N. Complement proteins are present in developing endochondral bone and may mediate cartilage cell death and vascularization. Experimental Cell Research 1996, 227(September (2)):208-213.
59. Ignatius A., Schoengraf P., Kreja L., Liedert A., Recknagel S., Kandert S., et al. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β. Journal of Cellular Biochemistry 2011, 112:2594-2605.
60. Schraufstatter I.U., Discipio R.G., Zhao M., Khaldoyanidi S.K. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. Journal of Immunology 2009, 182(March (6)):3827-3836.
61. Rousseau S., Dolado I., Beardmore V., Shpiro N., Marquez R., Nebreda A.R., et al. CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cellular Signalling 2006, 18(November (11)):1897-1905.
62. Pobanz J.M., Reinhardt R.A., Koka S., Sanderson S.D. C5a modulation of interleukin-1 beta-induced interleukin-6 production by human osteoblast-like cells. Journal of Periodontal Research 2000, 35(June (3)):137-145.
63. Jin C.H., Shinki T., Hong M.H., Sato T., Yamaguchi A., Ikeda T., et al. 1 alpha, 25-dihydroxyvitamin D3 regulates in vivo production of the third component of complement (C3) in bone. Endocrinology 1992, 131(November (5)):2468-2475.
64. Sato T., Hong M.H., Jin C.H., Ishimi Y., Udagawa N., Shinki T., et al. The specific production of the third component of complement by osteoblastic cells treated with 1 alpha, 25-dihydroxyvitamin D3. FEBS Letters 1991, 285(July (1)):21-24.
65. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423(May (6937)):337-342.
66. Tu Z., Bu H., Dennis J.E., Lin F. Efficient osteoclast differentiation requires local complement activation. Blood 2010, 116(November (22)):4456-4463.